Nelarabine induces complete remissions in adults with relapsed or refractory T-lineage acute lymphoblastic leukemia or lymphoblastic lymphoma: Cancer and Leukemia Group B study 19801. (Q33374461)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Nelarabine induces complete remissions in adults with relapsed or refractory T-lineage acute lymphoblastic leukemia or lymphoblastic lymphoma: Cancer and Leukemia Group B study 19801.	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

26 July 2017

Nelarabine induces complete remissions in adults with relapsed or refractory T-lineage acute lymphoblastic leukemia or lymphoblastic lymphoma: Cancer and Leukemia Group B study 19801. (English)

1 reference

Europe PubMed Central

26 July 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

lymphoblastic leukemia

1 reference

based on heuristic

inferred from title

lymphoblastic lymphoma

1 reference

based on heuristic

inferred from title

Richard A. Larson

object named as

Richard A Larson

10

0 references

Frederick R. Appelbaum

9

object named as

Frederick R Appelbaum

1 reference

Europe PubMed Central

26 July 2017

author name string

Daniel J DeAngelo

1

1 reference

Europe PubMed Central

26 July 2017

Daohai Yu

2

1 reference

Europe PubMed Central

26 July 2017

Jeffrey L Johnson

3

1 reference

Europe PubMed Central

26 July 2017

Steven E Coutre

4

1 reference

Europe PubMed Central

26 July 2017

Richard M Stone

5

1 reference

Europe PubMed Central

26 July 2017

Alison T Stopeck

6

1 reference

Europe PubMed Central

26 July 2017

Jon P Gockerman

7

1 reference

Europe PubMed Central

26 July 2017

Beverly S Mitchell

8

1 reference

Europe PubMed Central

26 July 2017

language of work or name

0 references

publication date

7 March 2007

1 reference

Europe PubMed Central

26 July 2017

1 reference

Europe PubMed Central

26 July 2017

109

1 reference

Europe PubMed Central

26 July 2017

5136-5142

1 reference

Europe PubMed Central

26 July 2017

12

1 reference

Europe PubMed Central

26 July 2017

SYNTHESIS OF 9-BETA-D-ARABINOFURANOSYLGUANINE.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1941786

14 July 2018

Treatment of adult acute lymphoblastic leukemia.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1941786

14 July 2018

Specific cytotoxicity of arabinosylguanine toward cultured T lymphoblasts

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1941786

14 July 2018

Metabolism and selective cytotoxicity of 9-beta-D-arabinofuranosylguanine in human lymphoblasts.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1941786

14 July 2018

Report of the National Cancer Institute-sponsored workshop on definitions of diagnosis and response in acute myeloid leukemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1941786

14 July 2018

Pharmacologic purging of malignant T cells from human bone marrow using 9-beta-D-arabinofuranosylguanine.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1941786

14 July 2018

Phase I study of 506U78 administered on a consecutive 5-day schedule in children and adults with refractory hematologic malignancies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1941786

31 October 2018

Phase II study of nelarabine (compound 506U78) in children and young adults with refractory T-cell malignancies: a report from the Children's Oncology Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1941786

31 October 2018

A single high dose of idarubicin combined with high-dose ARA-C for treatment of first relapse in childhood 'high-risk' acute lymphoblastic leukaemia: a study of the AIEOP group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1941786

31 October 2018

Selective toxicity of deoxyguanosine and arabinosyl guanine for T-leukemic cells.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1941786

31 October 2018

Metabolic basis of arabinonucleoside selectivity for human leukemic T- and B-lymphoblasts

1 reference

https://pubmed.ncbi.nlm.nih.gov/17344466

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Differential metabolism of 9-beta-D-arabinofuranosylguanine in human leukemic cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/17344466

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

2-Amino-6-methoxypurine arabinoside: an agent for T-cell malignancies

1 reference

https://pubmed.ncbi.nlm.nih.gov/17344466

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of adults with acute lymphoblastic leukaemia in first bone marrow relapse: results of the ALL R-87 protocol

1 reference

https://pubmed.ncbi.nlm.nih.gov/17344466

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Sensitivity of T-leukemic cells to deoxyguanosine and arabinosyl guanine

1 reference

https://pubmed.ncbi.nlm.nih.gov/17344466

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

ALL R-87 protocol in the treatment of children with acute lymphoblastic leukaemia in early bone marrow relapse

1 reference

https://pubmed.ncbi.nlm.nih.gov/17344466

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Compound GW506U78 in refractory hematologic malignancies: relationship between cellular pharmacokinetics and clinical response

1 reference

https://pubmed.ncbi.nlm.nih.gov/17344466

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Primary refractory and relapsed adult acute lymphoblastic leukemia: characteristics, treatment results, and prognosis with salvage therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/17344466

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacokinetics of nelarabine and 9-beta-D-arabinofuranosyl guanine in pediatric and adult patients during a phase I study of nelarabine for the treatment of refractory hematologic malignancies

1 reference

https://pubmed.ncbi.nlm.nih.gov/17344466

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Purine nucleoside synthesis, an efficient method employing nucleoside phosphorylases

1 reference

https://pubmed.ncbi.nlm.nih.gov/17344466

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1182/BLOOD-2006-11-056754

1 reference

Europe PubMed Central

26 July 2017

1 reference

Europe PubMed Central

26 July 2017

1 reference

Europe PubMed Central

26 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33374461&oldid=1957642978"